COMMUNIQUÉS West-GlobeNewswire

Shire plc: Rule 2.9 Announcement
31/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 31 August 2018 [...]
DBV Technologies to Attend Upcoming Investor Conferences
31/08/2018
Montrouge, France, August 31, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies invitée à présenter lors des prochaines Conférences Investisseurs
31/08/2018
Montrouge, France, le 31 aout (7H30 CEST), 2018 DBV Technologies invitée à présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]
Correction: On “Grindeks” Results in the First Six Months of 2018
31/08/2018
Notice: missed attachment of the company's financial statements of Q2 added. Turnover of “Grindeks” reaches 71.5 million euro in the first six months of 2018; profit – 6.7 million euro Today, on 30 August, the JSC “ [...]
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.
31/08/2018
Amsterdam, The Netherlands - 31 August 2018 Esperite NV announced mid-August that the Company had solved the technical issues that caused the delay regarding the publication of the Annual Report 2017. The departments [...]
Kiadis Pharma announces Financial Results for the six months ended June 30, 2018 and Company update
31/08/2018
Kiadis Pharma announces Financial Results for the six months ended June 30, 2018 and Company update Amsterdam, The Netherlands, August 31, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam [...]
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 August 2018
31/08/2018
Company Release no. 16/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 August 2018 Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 August 2018 Veloxis Pharmaceuticals A/S [...]
Reata Announces Receipt of $30 Million Milestone Payment From Kyowa Hakko Kirin
31/08/2018
IRVING, Texas, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced that it has received a $30 million milestone payment from its [...]
MacroGenics Announces Participation in Three Upcoming Investor Conferences
31/08/2018
Rockville, MD, Aug. 30, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Merus participera à la 13ème Conférence annuelle sur les biotechnologies de Citi
30/08/2018
UTRECHT, Pays-Bas, 30 août 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), une société d'immuno-oncologie au stade clinique qui développe des traitements innovants à base d'anticorps bispécifiques (Biclonics®), a [...]
Dentsply Sirona to Present at the Baird 2018 Global Healthcare Conference on September 5th
30/08/2018
YORK, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq:XRAY), The Dental Solutions Company, today announced it will participate in the Baird 2018 Global Healthcare Conference on [...]
Trevena to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
CHESTERBROOK, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today, announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, [...]
Marinus Pharmaceuticals to Present at the Baird Healthcare Conference
30/08/2018
RADNOR, Pa., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]
The Cooper Companies Announces Third Quarter 2018 Results
30/08/2018
PLEASANTON, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced financial results for the fiscal third quarter ended July 31, 2018. Revenue increased 19% year-over-year to $ [...]
Crinetics Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
30/08/2018
SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
HTG Molecular to Present a Corporate Overview at the H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018
TUCSON, Ariz., Aug. 30, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ [...]
AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 10, 2018
30/08/2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
Medigus Ltd Announces Second Quarter 2018 Financial Results
30/08/2018
OMER, Israel, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization [...]
Mersana Therapeutics to Present at Upcoming Investor Conferences
30/08/2018
CAMBRIDGE, Mass., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]

Pages